Frontiers | M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance
Effect of Disease State on the Pharmacokinetics of Bedaquiline in Renal-Impaired and Diabetic Rats | ACS Omega
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence | European Respiratory Society
Bedaquiline | Uses, Brand Names, Mechanism Of Action
Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance - ScienceDirect
Science News Highlights - Mechanism of action of tuberculosis drug Using Cryo-EM, the authors show that how anti-TB drug bedaquiline binds to ATP synthase and disrupts its synthesis of the molecule ATP.
Antibiotics | Free Full-Text | Re-Understanding the Mechanisms of Action of the Anti-Mycobacterial Drug Bedaquiline
Antibiotics | Free Full-Text | Re-Understanding the Mechanisms of Action of the Anti-Mycobacterial Drug Bedaquiline
The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics | Nature Reviews Chemistry
TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of Mycobacterium tuberculosis F-ATP Synthase | Antimicrobial Agents and Chemotherapy
SIRTURO® (bedaquiline)| Mechanism of Action| Official Website
IJMS | Free Full-Text | The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG
Bedaquiline - Wikipedia
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis | SpringerLink
Mechanism of action of Pyrazinamide and associated drug resistance... | Download Scientific Diagram
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs - ScienceDirect
Extensively drug-resistant tuberculosis: new strains, new challenges | Microbial Drug Resistance
Frontiers | Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
Bedaquiline inhibits the yeast and human mitochondrial ATP synthases | Communications Biology
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline | NEJM
Frontiers | Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Tuberculosis Drugs and Mechanisms of Action | NIH: National Institute of Allergy and Infectious Diseases
Novel Treatments for Drug-Resistant Tuberculosis - Jeremy M. Clain, Patricio Escalante, 2016
Tuberculosis Drugs and Mechanisms of Action | NIH: National Institute of Allergy and Infectious Diseases
